We have successfully accomplished a catalytic asymmetric
total
synthesis of entecavir, a first-line antihepatitis B virus medication.
The pivotal aspect of our strategy lies in the utilization of a Pd-catalyzed
enyne borylative cyclization reaction, enabling the construction of
a highly substituted cyclopentene scaffold with exceptional stereoselectivity.
Additionally, we efficiently accessed the crucial 1,3-diol enyne system
early in our synthetic route through a diarylprolinol organocatalyzed
enantioselective cross-aldol reaction and Re-catalyzed allylic alcohol
relocation. By strategically integrating these three catalytic protocols,
we established a practical pathway for acquiring valuable densely
heteroatom-substituted cyclopentene cores.